"The fight against pediatric brain cancer is a testament to human ingenuity and compassion, a beacon of hope in the quest to preserve childhood."
That's what the UK's Royal Marsden NHS Foundation Trust and the Institute of Cancer Research have to say about strides being made in the fight against the second most common cancer among children, central nervous system tumors, or diencephalic tumors.
In a press release, they write that "recent strides are illuminating paths previously shrouded in darkness, promising not just survival, but a life worth living post-treatment."
One such path is the use of tocilizumab, a treatment that blocks the body's own immune system from attacking brain tumors.
It's been used to treat gliomas, the most common form of brain cancer in children, and it's been shown to be more effective than chemo.
The Guardian reports that tocilizumab was also found to be more effective than chemo in another group of children with diencephalic tumors, and it's been used to delay surgery in some cases.
"It is not merely about extending lives but enriching them, ensuring that children facing the shadow of brain cancer can look forward to a future not defined by their illness but illuminated by their potential," the authors
A customized collection of grant news from foundations and the federal government from around the Web.
Caroline Diehl is a serial social entrepreneur in the impact media space. She is Executive Chair and Founder of the UK’s only charitable and co-operatively owned national broadcast television channel Together TV, the leading broadcaster for social change runs a national TV channel in the UK and digital platform which helps people find inspiration to do good in their lives and communities.